Cargando…

Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students

INTRODUCTION: Pharmacology is an important learning topic in preclinical medical education. Simulated patient encounters allow students to apply basic science knowledge in a clinical setting and have been useful in previous studies of pharmacology education. We developed a standardized patient (SP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Michael K., Gupta, Karisma R., Peters, Timothy R., Beardsley, James R., Jackson, Jennifer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of American Medical Colleges 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038986/
https://www.ncbi.nlm.nih.gov/pubmed/35539004
http://dx.doi.org/10.15766/mep_2374-8265.11242
_version_ 1784694022358433792
author Jones, Michael K.
Gupta, Karisma R.
Peters, Timothy R.
Beardsley, James R.
Jackson, Jennifer M.
author_facet Jones, Michael K.
Gupta, Karisma R.
Peters, Timothy R.
Beardsley, James R.
Jackson, Jennifer M.
author_sort Jones, Michael K.
collection PubMed
description INTRODUCTION: Pharmacology is an important learning topic in preclinical medical education. Simulated patient encounters allow students to apply basic science knowledge in a clinical setting and have been useful in previous studies of pharmacology education. We developed a standardized patient (SP) encounter to reinforce antiviral pharmacology content for first-year medical students. METHODS: Students were instructed to recommend a medication for shingles during an SP encounter and to answer questions from the SP on mechanism of action and adverse effects. Students then attended a large-group debrief session. Following the activity, students evaluated the exercise through a voluntary survey. For knowledge assessment, students were randomized into two groups to complete three multiple-choice questions either before or after the learning activity. RESULTS: In 2020 and 2021, 144 and 145 students, respectively, participated. In 2020, there was no significant difference in the proportion of correct answers between the pre- and postsimulation groups (p > .05). In 2021, the postsimulation group significantly outperformed the presimulation group in knowledge of mechanism of action (p < .01) and adverse effects (p < .01), but no difference was seen between the groups regarding medication selection (p = .27). Most learners assessed the instructional design as effective for the tasks assigned. DISCUSSION: This SP activity provided an opportunity for early medical students to practice integrating antiviral pharmacology knowledge into a patient encounter and was well received by learners. The instructional method offers a clinically relevant approach for reinforcing pharmacology knowledge for preclinical medical students.
format Online
Article
Text
id pubmed-9038986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Association of American Medical Colleges
record_format MEDLINE/PubMed
spelling pubmed-90389862022-05-09 Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students Jones, Michael K. Gupta, Karisma R. Peters, Timothy R. Beardsley, James R. Jackson, Jennifer M. MedEdPORTAL Original Publication INTRODUCTION: Pharmacology is an important learning topic in preclinical medical education. Simulated patient encounters allow students to apply basic science knowledge in a clinical setting and have been useful in previous studies of pharmacology education. We developed a standardized patient (SP) encounter to reinforce antiviral pharmacology content for first-year medical students. METHODS: Students were instructed to recommend a medication for shingles during an SP encounter and to answer questions from the SP on mechanism of action and adverse effects. Students then attended a large-group debrief session. Following the activity, students evaluated the exercise through a voluntary survey. For knowledge assessment, students were randomized into two groups to complete three multiple-choice questions either before or after the learning activity. RESULTS: In 2020 and 2021, 144 and 145 students, respectively, participated. In 2020, there was no significant difference in the proportion of correct answers between the pre- and postsimulation groups (p > .05). In 2021, the postsimulation group significantly outperformed the presimulation group in knowledge of mechanism of action (p < .01) and adverse effects (p < .01), but no difference was seen between the groups regarding medication selection (p = .27). Most learners assessed the instructional design as effective for the tasks assigned. DISCUSSION: This SP activity provided an opportunity for early medical students to practice integrating antiviral pharmacology knowledge into a patient encounter and was well received by learners. The instructional method offers a clinically relevant approach for reinforcing pharmacology knowledge for preclinical medical students. Association of American Medical Colleges 2022-04-26 /pmc/articles/PMC9038986/ /pubmed/35539004 http://dx.doi.org/10.15766/mep_2374-8265.11242 Text en © 2022 Jones et al. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access publication distributed under the terms of the Creative Commons Attribution-NonCommercial (https://creativecommons.org/licenses/by-nc/4.0/) license.
spellingShingle Original Publication
Jones, Michael K.
Gupta, Karisma R.
Peters, Timothy R.
Beardsley, James R.
Jackson, Jennifer M.
Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students
title Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students
title_full Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students
title_fullStr Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students
title_full_unstemmed Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students
title_short Antiviral Pharmacology: A Standardized Patient Case for Preclinical Medical Students
title_sort antiviral pharmacology: a standardized patient case for preclinical medical students
topic Original Publication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038986/
https://www.ncbi.nlm.nih.gov/pubmed/35539004
http://dx.doi.org/10.15766/mep_2374-8265.11242
work_keys_str_mv AT jonesmichaelk antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents
AT guptakarismar antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents
AT peterstimothyr antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents
AT beardsleyjamesr antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents
AT jacksonjenniferm antiviralpharmacologyastandardizedpatientcaseforpreclinicalmedicalstudents